145 related articles for article (PubMed ID: 14568982)
1. A critical role for OX40 in T cell-mediated immunopathology during lung viral infection.
Humphreys IR; Walzl G; Edwards L; Rae A; Hill S; Hussell T
J Exp Med; 2003 Oct; 198(8):1237-42. PubMed ID: 14568982
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo activities of OX40 (CD134)-IgG fusion protein isoforms with different levels of immune-effector functions.
Taylor L; Bachler M; Duncan I; Keen S; Fallon R; Mair C; McDonald TT; Schwarz H
J Leukoc Biol; 2002 Sep; 72(3):522-9. PubMed ID: 12223520
[TBL] [Abstract][Full Text] [Related]
3. Signaling through OX40 (CD134) breaks peripheral T-cell tolerance.
Bansal-Pakala P; Jember AG; Croft M
Nat Med; 2001 Aug; 7(8):907-12. PubMed ID: 11479622
[TBL] [Abstract][Full Text] [Related]
4. Robust B cell immunity but impaired T cell proliferation in the absence of CD134 (OX40).
Pippig SD; Peña-Rossi C; Long J; Godfrey WR; Fowell DJ; Reiner SL; Birkeland ML; Locksley RM; Barclay AN; Killeen N
J Immunol; 1999 Dec; 163(12):6520-9. PubMed ID: 10586044
[TBL] [Abstract][Full Text] [Related]
5. Consequences of OX40-OX40 ligand interactions in langerhans cell function: enhanced contact hypersensitivity responses in OX40L-transgenic mice.
Sato T; Ishii N; Murata K; Kikuchi K; Nakagawa S; Ndhlovu LC; Sugamura K
Eur J Immunol; 2002 Nov; 32(11):3326-35. PubMed ID: 12555678
[TBL] [Abstract][Full Text] [Related]
6. Contribution of CD30/CD153 but not of CD27/CD70, CD134/OX40L, or CD137/4-1BBL to the optimal induction of protective immunity to Mycobacterium avium.
Flórido M; Borges M; Yagita H; Appelberg R
J Leukoc Biol; 2004 Nov; 76(5):1039-46. PubMed ID: 15316035
[TBL] [Abstract][Full Text] [Related]
7. Cloning of mouse Ox40: a T cell activation marker that may mediate T-B cell interactions.
Calderhead DM; Buhlmann JE; van den Eertwegh AJ; Claassen E; Noelle RJ; Fell HP
J Immunol; 1993 Nov; 151(10):5261-71. PubMed ID: 8228223
[TBL] [Abstract][Full Text] [Related]
8. 4-1BB and OX40 stimulation enhance CD8 and CD4 T-cell responses to a DNA prime, poxvirus boost vaccine.
Munks MW; Mourich DV; Mittler RS; Weinberg AD; Hill AB
Immunology; 2004 Aug; 112(4):559-66. PubMed ID: 15270726
[TBL] [Abstract][Full Text] [Related]
9. Characterization and application of two novel monoclonal antibodies against human OX40: costimulation of T cells and expression on tumor as well as normal gland tissues.
Xie F; Wang Q; Chen Y; Gu Y; Shi Q; Ge Y; Yu G; Wu H; Mao Y; Wang X; Zhou Y; Zhang X
Tissue Antigens; 2006 Apr; 67(4):307-17. PubMed ID: 16634867
[TBL] [Abstract][Full Text] [Related]
10. The generation of T cell memory: a review describing the molecular and cellular events following OX40 (CD134) engagement.
Weinberg AD; Evans DE; Thalhofer C; Shi T; Prell RA
J Leukoc Biol; 2004 Jun; 75(6):962-72. PubMed ID: 14996827
[TBL] [Abstract][Full Text] [Related]
11. T-cell costimulatory molecules: optimal targets for the treatment of allergic airway disease with monoclonal antibodies.
Kroczek R; Hamelmann E
J Allergy Clin Immunol; 2005 Oct; 116(4):906-9. PubMed ID: 16210068
[TBL] [Abstract][Full Text] [Related]
12. OX40 (CD134) engagement drives differentiation of CD4+ T cells to effector cells.
Huddleston CA; Weinberg AD; Parker DC
Eur J Immunol; 2006 May; 36(5):1093-103. PubMed ID: 16541471
[TBL] [Abstract][Full Text] [Related]
13. Role of tumor necrosis factor-related apoptosis-inducing ligand in immune response to influenza virus infection in mice.
Ishikawa E; Nakazawa M; Yoshinari M; Minami M
J Virol; 2005 Jun; 79(12):7658-63. PubMed ID: 15919918
[TBL] [Abstract][Full Text] [Related]
14. Activated T cells express the OX40 ligand: requirements for induction and costimulatory function.
Mendel I; Shevach EM
Immunology; 2006 Feb; 117(2):196-204. PubMed ID: 16423055
[TBL] [Abstract][Full Text] [Related]
15. Roles of OX40 in the development of murine experimental allergic conjunctivitis: exacerbation and attenuation by stimulation and blocking of OX40.
Fukushima A; Yamaguchi T; Ishida W; Fukata K; Yagita H; Ueno H
Invest Ophthalmol Vis Sci; 2006 Feb; 47(2):657-63. PubMed ID: 16431965
[TBL] [Abstract][Full Text] [Related]
16. The adjuvancy of OX40 ligand (CD252) on an HIV-1 canarypox vaccine.
Liu J; Ngai N; Stone GW; Yue FY; Ostrowski MA
Vaccine; 2009 Aug; 27(37):5077-84. PubMed ID: 19573639
[TBL] [Abstract][Full Text] [Related]
17. Role of T cell costimulation in anti-viral immunity.
Bertram EM; Dawicki W; Watts TH
Semin Immunol; 2004 Jun; 16(3):185-96. PubMed ID: 15130503
[TBL] [Abstract][Full Text] [Related]
18. The costimulation-regulated duration of PKB activation controls T cell longevity.
Song J; Salek-Ardakani S; Rogers PR; Cheng M; Van Parijs L; Croft M
Nat Immunol; 2004 Feb; 5(2):150-8. PubMed ID: 14730361
[TBL] [Abstract][Full Text] [Related]
19. Intraperitoneal Echinococcus multilocularis infection in C57BL/6 mice affects CD40 and B7 costimulator expression on peritoneal macrophages and impairs peritoneal T cell activation.
Mejri N; Gottstein B
Parasite Immunol; 2006 Aug; 28(8):373-85. PubMed ID: 16879309
[TBL] [Abstract][Full Text] [Related]
20. Coexpression of CD25 and OX40 (CD134) receptors delineates autoreactive T-cells in type 1 diabetes.
Endl J; Rosinger S; Schwarz B; Friedrich SO; Rothe G; Karges W; Schlosser M; Eiermann T; Schendel DJ; Boehm BO
Diabetes; 2006 Jan; 55(1):50-60. PubMed ID: 16380476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
